Journal of Sulfur Chemistry 83
tetrabutylammoniumbromidewasadded.Thereactionmixturewasstirredatroomtemperaturefor
3 days, poured onto crushed ice, extracted with chloroform and evaporated to dryness. The ethyl
acetate insoluble portion was recrystallized from ethanol to give bis-phenylhydrazone. Yield:
1
58%; mp = 146 ◦C. H NMR (CDCl3) δ: 3.04 (s, 4H), 6.86 (td, J = 7.5, 1.2 Hz, 2H), 6.88
(d, J = 7.5 Hz, 4H), 7.21 (t, J = 7.5 Hz, 4H), 7.30–7.49 (m, 6H), 7.80 (d, J = 8.4 Hz, 4H); 13
C
NMR (CDCl3) δ: 21.4, 113.4, 120.4, 125.4, 128.4, 128.8, 129.1, 137.4, 143.0, 144.8. Anal. Calcd.
for C28H26N4S2 (482.67): C 69.68, H 5.43, N 11.61; found: C 69.70, H 5.49, N 11.64.
3.7. General procedure for the reaction of 2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-
phenyl-1-ethanone (1a) with hydrazine
A mixture of ketone 1a (0.005 mol), hydrazinium sulfate (0.035 mol) and sodium acetate
(0.035 mol) in 30 ml of ethanol was heated to reflux condition for about 3 h. The reaction mixture
was then poured onto crushed ice, extracted with chloroform and evaporated to dryness. The
ethyl acetate insoluble portion was recrystallized from ethanol to give 3,6-diphenyl-2,7-dihydro-
1,4,5-thiadizepine.18 Yield: 62%; mp = 179 ◦C. 1H NMR (CDCl3) δ: 3.30 (d, J = 13.2 Hz, 2H),
3.66 (d, J = 13.2 Hz, 2H), 7.46 (m, 6H), 7.90 (m, 4H); 13C NMR (CDCl3) δ: 26.4, 127.1, 128.8,
130.2, 135.0, 151.8. GC-mass (m/z): 266.6 (100%), 232.2 (41%), 163.2 (93%). Anal. Calcd. for
C16H14N2S (266.36): C 72.15, H 5.30, N 10.52; found: C 72.17, H 5.36, N 10.55.
3.8. General procedure for the reaction of 2-(4,5-dihydro-1,3-thiazol-2-ylsulfanyl)-1-
phenyl-1-ethanone (1a) with ethylene diamine/o-phenylenediamine/ethanolamine/
o-aminophenol
To a solution of ketone 1a (0.005 mol) and appropriate dinucleophile (0.035 mol) in 30 ml of ethyl
alcohol was heated to reflux condition for about 3 h. The reaction mixture was then poured onto
crushed ice, extracted with chloroform and evaporated to dryness. The ethyl acetate insoluble
portion was recrystallized from ethanol to give 1-phenyl-2-(thiazolidin-2-ylidene)ethanone, 7a.
1
Yield: 75%; mp = 165 ◦C (reported = 168 ◦C) (17). H NMR (CDCl3) δ: 3.28 (t, J = 7.2 Hz,
2H), 3.95 (t, J = 7.2 Hz, 2H), 5.99 (s, 1H), 7.42 (m, 3H), 7.85 (m, 2H), 10.7 (bs, 1H); 13C NMR
(CDCl3) δ: 29.7, 49.7, 87.0, 127.0, 128.2, 130.8, 139.6, 169.8, 186.4. GC-mass (m/z): 204.7
(100%), 176.5 (86%), 144.8 (40%), 104.8 (52%). Anal. Calcd. for C16H14N2S (205.28): C 64.36,
H 5.40, N 6.82; found: C 64.40, H 5.45, N 6.83.
Acknowledgements
The authors thank DST, New Delhi, for assistance under the IRHPA program for the NMR facility.
References
(1) (a) Arsenyan, P.; Oberte, K.; Pudova, O.; Lukevics, E. Chem. Heterocycl. Compd. 2002, 38, 1437–1447.
(b) Morzherin, Y.Y.; Glukhareva, T.V.; Bakulev, V.A. Chem. Heterocycl. Compd. 2003, 39, 679–706.
(2) (a) Moawad, E.B.;Yousif, M.Y.; Metwally, M.A. Pharmazie 1989, 44, 820–822. (b) Kuroda, K.; Uchikurohane, T.;
Tajima, S.; Tsubata, K. US Patent, US 6,166,054; Chem. Abstr. 2001, 134, 38255.
(3) (a) El-Kashef, H.S.; E-Bayoumy, B.; Aly, T.I. Egypt J. Pharm. Sci. 1986, 27, 27–30. (b) Sasaki, T. Japan Patent,
70,27,573; Chem. Abstr. 1971, 74, 3629.
(4) (a) El-Bahaie, S.; Assy, M.G.; Hassanien, M.M. Pharmazie 1990, 45, 791–793. (b) Padmavathi, V.; Sumathi, R.P.;
Padmaja, A. J. Ecobiol. 2002, 14, 9–12.
(5) Thomas, E.W.; Nishizawa, E.E.; Zimmermann, D.C.; Williams, D.J. J. Med. Chem. 1985, 28, 442–446.
(6) Al-Smadi, M.; Ratrout, S. Molecules 2004, 9, 957–967.
(7) (a) Hurd, C.D.; Mori, R.I. J. Am. Chem. Soc. 1955, 77, 5359–5364. (b) Lalezari, I.; Shafiee, A.; Yalpani, M. J. Org.
Chem. 1973, 38, 338–340.